Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genexol-PM plus gemcitabine in recurrent and metastatic pancreatic adenocarcinoma
NCT02739633Phase 2Unknown
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Start
- Apr 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel polymeric micelle in pancreatic adenocarcinoma (PDAC), sponsored by Samyang Biopharmaceuticals Corporation. Status: unknown.
02
Drugs
paclitaxel polymeric micelle
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02739633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739633.